Based on the screening results we selected 3 representative breast cancer cell lines (BT-549, T47D and MDA-MB-231) for further experiments as they cover the range of SLFN11 expression observed at baseline (moderate, low and null compared to HFF). This evidence concerns the gene SLFN11 and breast cancer.